Liver regeneration: Mechanisms, mysteries and more

ANZ Journal of Surgery

Volumn 77, Issue 1-2, 2007, Pages 9-14

  Khan, Aamir Z ^a,b   Mudan, Satvinder S ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Royal Marsden Hospital   (United Kingdom)

Author keywords

Liver; Mechanism; Regeneration

Indexed keywords

EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INSULIN; INTERLEUKIN 6; NORADRENALIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DATA BASE; DNA SYNTHESIS; HUMAN; KUPFFER CELL; LIVER; LIVER CARCINOMA; LIVER CIRRHOSIS; LIVER HYPERTROPHY; LIVER REGENERATION; LIVER RESECTION; MEDLINE; NONHUMAN; PARTIAL HEPATECTOMY; PORTAL VEIN; PROTEIN SYNTHESIS; REVIEW; UPREGULATION;

APOPTOSIS; CYTOKINES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER REGENERATION;

EID: 33846406928     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2006.03981.x     Document Type: Review

References (72)

1. Taub R. Liver regeneration 4: transcriptional control of liver regeneration. FASEB J. 1996; 10: 413-27.
2. Zimmerman A. Liver regeneration: the emergence of new pathways. Med. Sci. Monit. 2002; 8: 53-63.
3. Couinaud C. Liver anatomy: portal and suprahepatic or biliary segmentation. Dig. Surg. 1999; 16: 459-67.
4. Higgins GM, Anderson RM. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 1931; 12: 186-202.
5. Nagasue N, Yukaya H, Ogawa Y et al. Human liver regeneration after liver resection. A study of normal livers and livers with chronic hepatitis and cirrhosis. Ann. Surg. 1987; 206: 30-39.
6. Mose MJ, Gong Y, Zhang MN et al. Immediate early oncogene expression and liver function following various extents of partial hepatectomy in the rat. Dig. Dis. Sci. 2001; 46: 907-14.
7. Grompe M. The role of bone marrow stem cells in liver regeneration. Semin. Liver Dis. 2003; 23: 363-72.
8. Pomfret EA, Pomposelli JJ, Gordon FD. Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation 2003; 76: 5-10.
9. Kwon KH, Kim YW, Kim SI et al. Postoperative liver regeneration and complication in live liver donor after partial hepatectomy for living donor liver transplantation. Yonsei Med. J. 2003; 44: 1069-77.
10. Bozhkov AI, Maleev VA. [Does the liver ability to regeneration decrease with age? The dynamics of functional activity of mitochondria in process of the liver regeneration.] Adv. Gerontol. 2004; 13: 58-65. (In Russian.)
11. Bucher NLR. Regeneration of the mammalian liver. Int. Rev. Cytol. 1963; 15: 245-94.
12. Kountouras J, Boura P, Lygidakis NJ. Liver regeneration after hepatectomy. Hepatogastroenterology 2001; 48: 556-62.
13. Souto M, Llanos J. The circadian optimal time for hepatectomy in the study of liver regeneration. Chronobiol. Int. 1985; 2: 169-75.
14. Barbason H, Herens C, Robaye B, Milis G et al. Importance of cell kinetics rhythmicity for the control of cell proliferation and carcinogenesis in rat liver. In Vivo. 1995; 9: 539-48.
15. Michalopoulos GK, Defrances MC. Liver regeneration. Science 1997; 276: 60-66.
16. Grisham J. A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regeneration in the liver: autoradiography with thymidine-H3. Cancer Res. 1964; 22: 842-9.
17. Widman JJ, Fahimi HD. Proliferation of mononuclear phagocytes (Kupffer cells) and endothelial cells in regeneration rat liver. Am. J. Pathol. 1975; 80: 349-66.
18. Rabes HM, Wirsching R, Tuczek HV et al. Analysis of cell cycle compartments after partial hepatectomy. Cell Tissue Kinet. 1976; 9: 517-32.
19. Fernandez-Salguero P. Immune system impairment and hepatic fibrosis in mice lacking dioxin binding Ah receptor. Science 1995; 268: 722-6.
20. Schweixer W, Duda P, Tanner S et al. Experimental atrophy/hypertrophy complex (AHC) of the liver: portal vein but not bile duct obstruction is the main driving force for the development of AHC in the rat. J. Hepatol. 1995; 23: 71-8.
21. Yamanaka N, Okamoto E, Kawamura E et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of compute tomography and liver function. Hepatology 1993; 18: 79-85.
22. Miwa S, Miyagawa S. [Liver regeneration after hepatectomy.] Nippon Geka Gakkai Zasshi 2004; 105: 654-7. (In Japanese.)
23. Jin MB, Shimamura T, Taniguchi M et al. [Liver regeneration in living-donor liver transplantation.] Nippon Geka Gakkai Zasshi 2004; 105: 674-9. (In Japanese.)
24. Zajicek G, Arber N, Schwartz-Arad D. Streaming liver. VIII: cell production rates following partial hepatectomy. Liver 1991; 11: 347-51.
25. Higashiyama H, Yamaguchi T, Mori K et al. Graft size assessment by preoperative computed tomography in living related partial liver transplantation. Br. J. Surg. 1993; 80: 489-92.
26. LaBrecque D. Liver regeneration: a picture emerges from the puzzle. Am. J. Gastroenterol. 1994; 89 (Suppl.): S86-96.
27. Recknagel R. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Ther. 1989; 43: 139-54.
28. Fan ST, Lo CM, Lai EC et al. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N. Engl. J. Med. 1994; 331: 1547-52.
29. Luo SM, Liang LJ, Lai LM. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis. World J. Gastroenterol. 2004; 10: 1292-6.
30. Lou G, Zhang M, Minuk GY. The effects of acute ethanol exposure on polyamine and gamma-aminobutyric acid metabolism in the regenerating liver. Alcohol 1999; 19: 219-27.
31. Michalopoulos G, Houck KA, Dolan ML et al. Control of hepatocyte replication by two serum factors. Cancer Res. 1984; 44: 4414-19.
32. Moolten FL, Bicher NLR. Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 1967; 158: 272-4.
33. Huh C. Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration repair. Proc. Natl Acad. Sci. USA 2004; 101: 4477-82.
34. Pediaditakis P, Lopez-Talavera JC, Peterson B et al. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001; 34: 688-93.
35. Burr AW, Toole K, Chapman C et al. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J. Pathol. 1998; 185: 298-302.
36. Okano J, Shiotal G, Matsumoto K et al. Hepatocyte growth factor exerts a proliferative effect on oval cells through the PI3K/AKT signaling pathway. Biochem. Biophys. Res. Commun. 2003; 309: 298-304.
37. Matsumoto K, Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncog. 1992; 3: 27-54.
38. Scheving LA Stevenson MC, Taylormoore JM et al. Integral role of the EGF receptor in HGF-mediated hepatocyte proliferation. Biochem. Biophys. Res. Commun. 2002; 290: 197-203.
39. Webber AM, Godowski PJ, Fasuto N. In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 1994; 19: 489-97.
40. Cressman DE, Greenbaumm LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-83.
41. Fausto N, Laird AD, Webber E. Liver regeneration. Role of growth factors and cytokines in hepatic regeneration. FASEB J. 1995; 9: 1527-36.
42. Olsen PS, Poulsen SS, Kirkgaard P. Adrenergic effects of secretion of epidermal growth-factor from Brunner's glands. Gut 1985; 26: 920-27.
43. Cruise JL, Houck KA, Michalopoulos GK. Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science 1985; 227: 749-51.
44. Cruise JL, Michalopoulos GK. Norepinephrine and epidermal growth factor: dynamics of their interaction in the stimulation of hepatocyte DNA synthesis. J. Cell. Physiol. 1985; 125: 45-50.
45. Houck KA, Michalopoulous GK. Altered responses of regenerating hepatocytes to norepinephrines and transforming growth factor type-beta. J. Cell. Physiol. 1989; 141: 503-9.
46. Starzl TE, Francavilla KA, Porter J et al. Liver regeneration in dogs: morphologic and chemical changes. J. Surg. Res. 1978; 25: 409-19.
47. Drixler TA, Vogten JM, Gebbink MFBG et al. Plasminogen mediates liver regeneration and angiogenesis after experimental partial hepatectomy. Br. J. Surg. 2003; 90: 1384-90.
48. Mack C, Jungermann K, Gotze O. Anaphylatoxin C5a actions in rat liver: synergistic enhancement by C5a of lipopolysaccharide-dependent alpha(2)-macroglobulin gene expression in hepatocytes via IL-6 release from Kupffer cells. J. Immunol. 2001; 167: 3972-9.
49. Puschel GP, Opperman M, Neuschafer-Rube F et al. Differential effects of human anaphylatoxin C3a on glucose output and flow in rat liver during orthograde and retrograde perfusion: the periportal scavenger cell hypothesis. Biochem. Biophys. Res. Commun. 1991; 176: 1218-26.
50. Kinosita R. Studies on the cancerogenic chemical substances. Trans. Soc. Pathol. Jpn 1937; 27: 665-727.
51. Laperche Y. Oval cells and liver regeneration. Med. Sci. (Paris) 2003; 19: 697-8.
52. Lowes KM, Croager EJ, Olynyk JK et al. Oval cell mediated liver regeneration: role of cytokines and growth factors. J. Gastroenterol. Hepatol. 2003; 18: 4-12.
53. Ochiai K, Muramatsu H, Yamamoto S. The role of midkine and pleiotrophin in liver regeneration. Liver Int. 2004; 24: 484-91.
54. Macias-Silva M, Li W, Leu JI et al. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J. Biol. Chem. 2002; 277: 28 483-90.
55. Auth MKH, Joplin RE, Okamato M et al. Morphogenesis of primary biliary epithelial cells: induction in high-density culture or by coculture with autologous human hepatocytes. Hepatology 2001; 33: 519-29.
56. Ronco MT, Alvarez Mde L, Monti JA. Role of nitric oxide increase on induced programmed cell death during early stages of rat liver regeneration. Biochim. Biophys. Acta 2004; 1690: 70-76.
57. Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J. Vasc. Interv. Radiol. 2005; 16: 779-90.
58. Makuuchi M, Thai BL, Takayasu K et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521-7.
59. Kobayashi T, Imamura H, Aoki T et al. Morphological regeneration and hepatic functional mass after right hemihepatectomy. Dig. Surg. 2006; 23: 44-50.
60. Nagino M, Nimura Y, Kamiya J et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995; 21: 434-9.
61. Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: strategies and controversies in 2006. Eur. J. Surg. Oncol. 2006; 32: 473-83.
62. Shimada H, Tanaka K, Matsuo K et al. Treatment for multiple bilobar liver metastases of colorectal cancer. Langenbecks Arch. Surg. 2006; 391: 130-42.
63. Liem MS, Liu CL, Tso WK et al. Portal vein embolisation prior to extended right-sided hepatic resection. Hong Kong Med. J. 2005; 11: 366-72.
64. Liu H, Fu Y. Portal vein embolization before major hepatectomy. World J. Gastroenterol. 2005; 11: 2051-4.
65. Elias D, Santoro R, Ouellet JF et al. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology 2004; 51: 1788-91.
66. Takayasu K, Muramatsu Y, Shima Y et al. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986; 160: 389-93.
67. Shimamura T, Nakajima Y, Une Y et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 1997; 121: 135-41.
68. Denys A, Lacombe C, Schneider F et al. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J. Vasc. Interv. Radiol. 2005; 16: 1667-74.
69. Lee KC, Kinoshita H, Hirohashi K et al. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J. Surg. 1993; 17: 109-15.
70. Goto Y, Nagino M, Nimura Y. Doppler estimation of portal blood flow after percutaneous transhepatic portal vein embolization. Ann. Surg. 1998; 228: 209-13.
71. Vauthey JN, Chaoui A, Do KA et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127: 512-19.
72. Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26: 1176-81.